85. 特発性間質性肺炎 Idiopathic interstitial pneumonia Clinical trials / Disease details
臨床試験数 : 627 / 薬物数 : 443 - (DrugBank : 120) / 標的遺伝子数 : 99 - 標的パスウェイ数 : 212
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00981747 (ClinicalTrials.gov) | September 2009 | 19/9/2009 | Targeting Vascular Reactivity in Idiopathic Pulmonary Fibrosis | A Clinical Treatment Trial Targeting Vascular Reactivity in Idiopathic Pulmonary Fibrosis | Idiopathic Pulmonary Fibrosis;Pulmonary Fibrosis | Drug: Sildenafil;Drug: Losartan;Drug: Sildenafil and Losartan;Drug: Placebo Oral Tablet | Alicia Gerke | Pulmonary Fibrosis Foundation | Terminated | 18 Years | 99 Years | All | 12 | Phase 2/Phase 3 | United States |